Manager, Innovation Strategy and Solutions at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Strong technical and analytical capabilities, particularly in R programming (including Shiny applications and R package development)
Preferably Python, with working knowledge of CDISC standards and clinical development workflows
Familiarity with SAS is a plus for integration with legacy environments
Ability to work independently and collaboratively
Combining strategic thinking with technical execution

Responsibilities

Support the framing, assessment, and prioritization of internal and external innovation initiatives in collaboration with stakeholders across GBDS, focusing on delivering solutions that enhance efficiency and quality across clinical development activities
Apply expertise in R—including Shiny dashboards and package development—to design and prototype advanced tools and applications to support analytics, automation, and decision-making across GBDS
Leverage Python to support areas such as DevOps, data engineering, machine learning, or generative AI, where applicable
Provide strategic input on project direction and contribute to the technical architecture of solutions, ensuring they are scalable, maintainable, and aligned with GBDS’ data and analytics strategy
Partner with GBDS teams to propose, develop, and implement innovative solutions that streamline process execution across biometrics and the broader Global Drug Development organization
Ensure scientific validity and technical correctness of tools and platforms supporting clinical trial processes, ensuring fitness for regulatory submission and operational use
Promote solution governance by aligning development with internal policies, stakeholder workflows, and regulatory expectations

Skills

Shiny

Data Analysis

Innovation Strategy

Process Automation

Technology Implementation

Clinical Development

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free